These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6192598)

  • 1. [Interferon-inducing effect of influenza viruses following aerogenic and oral administration in NMRI mice].
    Schubert K; Bergmann KC; Noack K
    Z Erkr Atmungsorgane; 1983; 160(3):242-6. PubMed ID: 6192598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Occurrence of antibodies against influenza viruses in the lung, bile and sera of mice following aerogenous infection and oral or subcutaneous immunization].
    Tischner H; Pohl WD; Bergmann KC; Noack K; Luther P
    Z Erkr Atmungsorgane; 1983; 160(3):226-33. PubMed ID: 6880290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against influenza and stimulated macrophages in the lung lavage fluid of mice following oral immunization.
    Bergmann KC; Waldman RH
    Allerg Immunol (Leipz); 1983; 29(4):215-22. PubMed ID: 6229988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 60amino-6-deoxy-D-glucose hydrochloride on influenza infection in mice.
    Hrusková J; Jarý J; Danes L; Jelínková A; Novák M
    Acta Virol; 1975 Jan; 19(1):47-51. PubMed ID: 235197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of influenza specific antibodies in the lung after oral immunization in mice.
    Bergmann KC; Waldman RH
    Poumon Coeur; 1982; 38(5):289-92. PubMed ID: 7155999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental animal model of airborne influenza infection].
    Noack K; Bergmann KC; Eckert H; Luther P; Tischner H; Pohl WD
    Z Erkr Atmungsorgane; 1982; 159(2):155-65. PubMed ID: 6762781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection.
    Tsurita M; Kurokawa M; Imakita M; Fukuda Y; Watanabe Y; Shiraki K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):362-8. PubMed ID: 11408563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from lethal influenza virus challenge by oral type 1 interferon.
    Beilharz MW; Cummins JM; Bennett AL
    Biochem Biophys Res Commun; 2007 Apr; 355(3):740-4. PubMed ID: 17316562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
    Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
    Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral application of an immunomodulating plant extract on Influenza virus type A infection in mice.
    Bodinet C; Mentel R; Wegner U; Lindequist U; Teuscher E; Freudenstein J
    Planta Med; 2002 Oct; 68(10):896-900. PubMed ID: 12391552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a murine hypothermia model for study of respiratory tract influenza virus infection.
    Wong JP; Saravolac EG; Clement JG; Nagata LP
    Lab Anim Sci; 1997 Apr; 47(2):143-7. PubMed ID: 9150492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergency prophylactic effects of the avian influenza virus immunized serum on the infected mice].
    Wang CY; Wang HL; Feng N; Yang ST; Gao YW; Wang TC; Zou XH; Xia XZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Nov; 42(11):814-7. PubMed ID: 19176141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of beta interferon in host defense against influenza A virus.
    Koerner I; Kochs G; Kalinke U; Weiss S; Staeheli P
    J Virol; 2007 Feb; 81(4):2025-30. PubMed ID: 17151098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The simple method of direct estimation of infectious process in mice and rats aerogenically infected with influenza virus].
    Sergeev AN; Zhukov VA; Poryvaev VD; P'ankov OV; Shishkina LN; Petrishchenko VA; P'ankova OG; Bulychev LE; Safatov AS
    Vopr Virusol; 2002; 47(4):44-6. PubMed ID: 12271727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of influenza viral infection through the murine respiratory tract: the protective role of sleep deprivation.
    Renegar KB; Crouse D; Floyd RA; Krueger J
    Sleep; 2000 Nov; 23(7):859-63. PubMed ID: 11083594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peculiarities of influenza infection caused by highly and poorly immunogenic strains of influenza virus.
    Frolov AF; Skripchenko GS; Shcherbinskaya AM; Vlasova AG; Rybakova TM
    J Hyg Epidemiol Microbiol Immunol; 1984; 29(3):303-9. PubMed ID: 6544322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.